Dinara Safina thinks Iga Swiatek is very good at "disguising" her emotions but the former world No. 1 is not ruling the possibility of the Pole "crumbling" following the doping news.

Swiatek, 23, tested positive in August for a banned heart medication. She blamed it on the sleeping medicine melatonin.

The Polish player was ranked world number one when she provided a sample containing the angina medication trimetazidine in an out-of-competition test on 12 August.

Iga Swiatek, the No. 2 ranked women's tennis player in the world, has accepted a one-month suspension for violating the Tennis Anti-Doping Program, the International Tennis Integrity Agency announced on Thursday.

The International Tennis Integrity Agency says five-time Grand Slam champion Iga Swiatek has accepted a one-month suspension after testing positive for the banned substance trimetazidine.

Iga Swiatek hopes to put the one-month doping ban behind her as quickly as possible, as she aims to get back on track in 2025.

WTA World No. 2 Iga Swiatek continues to make changes to her team in the last few months of 2024. After almost four years, Swiatek has parted ways with her Public Relations Manager, Paula Wolecka. According to a statement from the Polish public relations agency PRoto,

Iga Swiatek's doping controversy refuses to die down. The post Tennis Controversy: Iga Swiatek’s Doping Drama Highlights Double Standards as Frustrated Insider Minces No Words appeared first on EssentiallySports.